IL-1 gene cluster polymorphisms and development of primary gastric B-cell lymphoma in Helicobacter pylori infection [5]

Blood

Volumn 104, Issue 9, 2004, Pages 2994-2995

  Hellmig, Stephan ^a   Vollenberg, Steffen ^a   Goebeler Kolve, Maria Elisabeth ^a   Fischbach, Wolfgang ^a   Hampe, Jochen ^a   Fölsch, Ulrich Robert ^a   Schreiber, Stefan ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; INTERLEUKIN 1; INTERLEUKIN 1BETA;

ADULT; AGED; B CELL LYMPHOMA; BACTERIAL INFECTION; BACTERIAL VIRULENCE; CANCER RISK; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL ENDOSCOPY; GENE LOCUS; GENOTYPE; HAPLOTYPE; HELICOBACTER PYLORI; HUMAN; INFLAMMATION; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH BIOPSY; STOMACH LYMPHOMA;

HELICOBACTER PYLORI;

EID: 7444231711     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-05-1792     Document Type: Letter

References (9)

1. Hwang IR, Kodama T, Kikuchi S, et al. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1 beta production in Helicobacter pylori infection. Gastroenterology. 2002;123:1793-1803.
2. El-Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature. 2000;404:398-402.
3. Rollinson S, Levene AP, Mensah FK, et al. Gastric marginal zone lymphoma is associated with polymorphisms in genes involved in inflammatory response and antioxidative capacity. Blood. 2003;102:1007-1011.
4. Fischbach W, Dragosics B, Kolve-Goebeler ME, et al. Primary gastric B-cell lymphoma: results of a prospective multicenter study. The German-Austrian Gastrointestinal Lymphoma Study Group. Gastroenterology. 2000;119:1191-1202.
5. Chelstrom LM, Finnegan D, Uckun FM. Treatment of BCL-1 murine B-cell leukemia with recombinant cytokines: comparative analysis of the anti-leukemic potential of interleukin 1 beta (IL-1 beta), interleukin 2 (IL-2), interleukin-6 (IL-6), tumor necrosis factor alpha (TNF alpha), granulocyte colony stimulating factor (G-CSF), granuiocyte-macrophage colony stimulating factor (GM-CSF), and their combination. Leuk Lymphoma. 1992;7:79-86.
6. Carbone PP, Kaplan HS, Musshoff K, et al. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res. 1971;31:1860-1861.
7. Musshoff K. [Clinical staging classification of non-Hodgkin's lymphomas (author's transl)]. Strahlentherapie. 1977;153:218-221.
8. Radaszkiewicz T, Dragosics B, Bauer P. Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis. Gastroenterology. 1992;102:1628-1638.
9. Krawczak M, Konecki DS, Schmidtke J, et al. Allelic association of the cystic fibrosis locus and two DNA markers, XV2c and KM19, in 55 German families. Hum Genet. 1988;80:78-80.